Print

Bio-Path Holdings, Inc. (BPTH) Reports Third Quarter 2012 Operational and Financial Results  
11/16/2012 9:26:29 AM

HOUSTON--(BUSINESS WIRE)--Bio-Path Holdings, Inc., (OTCQX: BPTH) (“Bio-Path”), a biotechnology company developing a liposomal delivery technology for nucleic acid cancer drugs, today announced operational and financial results for the quarter ended September 30, 2012.
//-->